Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Observational Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps Treated by FASENRA®

NCT05180357 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05180357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Observational Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps Treated by FASENRA®
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 23, 2021
Completion date
October 28, 2022
Enrollment
273 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

nasal polyps, severe eosinophilic asthma